Eton Pharmaceuticals (ETON) Change in Cash (2018 - 2025)

Eton Pharmaceuticals has disclosed Change in Cash across 8 years of filings, most recently posting -$11.2 million for Q4 2025.

• In Q4 2025, Change in Cash fell 109.93% year-over-year to -$11.2 million; the TTM figure through Dec 2025 stood at $11.0 million (up 270.58% YoY), while the FY2025 annual figure was $11.0 million, up 270.58% from the prior year.
• Change in Cash came in at -$11.2 million for Q4 2025 at Eton Pharmaceuticals, down from $11.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $11.7 million in Q3 2025 to a low of -$11.2 million in Q4 2025.
• Average Change in Cash over 5 years is $232350.0, with a median of $756000.0 recorded in 2021.
• Year-over-year, Change in Cash jumped 1319.33% in 2021 and slumped 680.79% in 2024.
• Over 5 years, Change in Cash stood at -$8.3 million in 2021, then soared by 135.25% to $2.9 million in 2022, then tumbled by 123.3% to -$682000.0 in 2023, then tumbled by 680.79% to -$5.3 million in 2024, then slumped by 109.93% to -$11.2 million in 2025.
• Per Business Quant data, the three most recent Change in Cash figures were -$11.2 million in Q4 2025, $11.7 million in Q3 2025, and $8.0 million in Q2 2025.